Patents News - Candlesense

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

RA'ANANA, Israel, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-suppor...

What assumptions underlie the $20 billion market estimate and how realistic is capturing a meaningful share? How does the newly approved patent strengthen Inspira's competitive position relative to other extracorporeal oxygenation providers? What is the expected timeline for commercial launch of the ART500 and its impact on near‑term revenue?

Symbol: IINN

2 days ago

Read more globenewswire

Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology

Notice of Allowance marks first Chinese patent to be issued on Anixa Breast Cancer Vaccine Expands global intellectual property coverage in markets with high breast cancer incidence New patent will...

What is the timing and likelihood of commercialization of the breast cancer vaccine in China, and how might it influence the stock's volatility? What competitive advantage does this IP protection give Anixa versus other breast cancer vaccine developers in China and globally? How will the new Chinese patent approval affect Anixa Biosciences' revenue forecasts and valuation?

Symbol: ANIX

4 days ago

Read more prnewswire

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and 57 patent applications pending.

Symbol: MBOT

4 days ago

Read more globenewswire

IonQ Fortifies Quantum Leadership with Groundbreaking Patents, Surpassing 1,000 Total IP Assets

COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the leading commercial quantum computing and quantum networking company, today announced significant advancements in its intellectual property...

Symbol: IONQ

4 days ago

FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis

-- Evofem now holds eleven Orange Book - listed patents covering SOLOSEC into late 2041 -- SAN DIEGO, Aug. 19, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCID: EVFM) today announced that a new...

Will the new patent trigger any competitive responses or licensing disputes that could impact the stock price? What is the expected market size and launch timeline for the SOLOSEC oral granules targeting BV and Trichomoniasis, and how does it compare to existing treatments? How will the extended patent protection for SOLOSEC affect Evofem's revenue projections and valuation?

Symbol: EVFM

5 days ago

Read more prnewswire

Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Treat Cancers

Strengthens Intellectual Property Estate for REQORSA Oncology Program with Immune Checkpoint Inhibitors AUSTIN, Texas, Aug. 18, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASD...

How does Genprex's IP position compare to other gene‑therapy companies, and could it enable licensing or partnership opportunities? What is the expected timeline for clinical milestones and potential revenue from the REQORSA oncology program with PD‑1/PD‑L1 antibodies? How will the expanded patent portfolio for Reqorsa® affect Genprex's valuation and near‑term stock price?

Symbol: GNPX

6 days ago

Read more prnewswire

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue

HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. patent No. 12,357,584 B2 entitled “Compositi...

Symbol: IBO

6 days ago

Read more globenewswire

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through pa...

What is the potential impact on the company's pipeline valuation if SCP-111 proves successful and funds further development projects? Are there any regulatory or reimbursement hurdles specific to the SCP-111 formulation that could impact its commercial rollout? How might the patent allowances influence analyst coverage, target price revisions, or institutional sentiment toward SCPH?

Symbol: SCPH

10 days ago

Read more globenewswire

Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology

Newly issued patent extends protection of proprietary solid tumor CAR-T platform to 2045 SAN JOSE, Calif., Aug. 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ...

How does this patent issuance align with broader industry trends in solid‑tumor CAR‑T research and development? What impact could the extended patent have on the company's ability to raise capital or secure debt financing? Is there any risk of patent challenges or prior‑art disputes that could offset the perceived benefits?

Symbol: ANIX

12 days ago

Read more prnewswire

vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin

HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-...

What is the potential impact on VTVT’s stock volatility and trading volume in the short term following the announcement? How might the market react to the sentiment score of 70 and the overall positive tone of the release? Will the patent allowance trigger any milestone payments or trigger clauses in existing collaborations or financing agreements?

Symbol: VTVT

13 days ago

Read more globenewswire